Bristol has demonstrated a strong commitment to building innovative and successful companies within the healthcare and life sciences industries. We pride ourselves on our ability to develop innovative financing solutions for our healthcare / life sciences clients, and provide a proactive, long-term investment perspective in the transactions we structure.

Even in the face of rapid technological development, changing reimbursement, regulatory environments, shifting investor sentiment and financing cycles, we deliver an unparalleled network of healthcare investors to support management teams that share a common objective of building durable businesses with sustainable value.

Bristol's healthcare team focuses on the following segments:

Medical Devices
Analytical Instruments, Anesthesia Products, Biomaterials, OB-GYN Products, Cardiovascular Devices, Catheters, Dental Products, Diagnostic Imaging, Drug Delivery, In Vitro Diagnostics, Endoscopy and Minimally Invasive Surgery Products, Kits and Trays, Ophthalmic Devices, Orthotic and Prosthetics, Packaging Products and Equipment, Pulmonary Devices, Specimen Collection Disposables, Women's Health, Surgical Instruments, Wound Care Items.

Pharmaceuticals
Anti-infectives, Blood Substitutes, Cancer Therapies, Cardio-Vascular Drugs, Contrast Agents, Dermatologicals, Drug Delivery Systems, Generics, Natural Products, Nutraceuticals, OTC Products, Pharmaceutical Packaging, Proteins, Vaccines, Veterinary, Wound Care.

Healthcare Information Systems
Billing Systems, Clinical Information Systems, Electronic Medical Records, Hospital Information Systems, Outcome Measurement Systems, Physician Practice Management Systems, Pictorial Archiving Communication Systems, Radiology Information Systems, Surgical Treatment Systems.

Biotechnology
Biochemical Products, Biotech Instruments, Human Diagnostics, Human Therapeutics.

Distribution
Dental Distribution, Direct Marketing (Catalog, Mail Order, On-Line Systems), Hospital Distribution, Private Practice Distribution, Specialty Distribution.

Medical Services
Clinical Laboratories, Diagnostic Imaging Services, Independent Medical Exams, Managed Care, Utilization Review.
Bristol augments its staff with healthcare advisors including:

Dr. William Prather is an advisor to Bristol. He has been Senior Vice President, Finance and Business Development of Boston Biomedica (NasdaqNM-BBII) since August 1999. Prior to joining the Company, Dr. Prather was the Senior Health Care Analyst for Cruttenden Roth, Inc. from 1995 to 1998. From 1992 to 1995 he was the Senior Analyst in Health Care for Manning and Napier Advisors. Dr. Prather earned a B.S. in pharmacy and his MD at the University of Missouri--Kansas City, and completed a Clinical Research Geriatric Fellowship at Harvard Medical School. Dr. Prather is a Director of Primed International, a medical device company and a member of the Advisory Board of the Canadian Medical Discovery Fund, Inc., a fund of MDS Capital Corp.

Our affiliated company, Wall Street Advisor, provides investment research on and marketing for healthcare and technology companies. We also sponsor the Wall Street Investor Council and the CEO Forum which provides companies with access to several hundred healthcare investment professionals. Our research is used by money managers, stockbrokers, financial planners, investment clubs, high net worth individuals, investor relations firms and individual investors who demand high-quality investment research information. Wall Street Advisor research is distributed through BusinessWire to over half a million money managers, stockbrokers, pension funds and other investors. We supplement this network with our own healthcare-specific investment professionals.

The following list provides an overview of our clients in the healthcare / life sciences industry:

	Nutrition 21 NXXI - NasdaqSC Nutrition 21, based in Purchase, NY, is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The function of insulin, the body’s master metabolic hormone, is in part dependent on chromium that must be supplied through diet or supplementation. The Company markets Chromax® chromium picolinate. Bristol's $9.6mm Financing | Research Report
	Delcath Systems, Inc. DCTH - NasdaqSC Delcath Systems has developed a patented system to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Delcath’s system delivers chemotherapy to the liver and cleanses the blood of the chemotherapy before its return from the liver. Research Report
	Stellar International Inc. SLRXF - OTCBB Stellar International Inc. develops and markets: 1) NeoVisc a viscosupplement, for the treatment of osteoarthritis and 2) Uracyst for the diagnosis and treatment of interstitial cystitis (an inflammatory disease of the urinary bladder wall). October 7, 2004 Report | November 17, 2004 Update
	SinoFresh HealthCare, Inc. SFSH - OTC BB SinoFresh HealthCare, Inc. develops and markets innovative ear, nose, and throat products that represent unique approaches to age-old health complaints. Our products can be found in the sinus remedies, allergy remedies, and throat relief aisles of most retail pharmacies. Bristol's Financing...
	Biophan Technology BIPH - OTC BB Biophan Technologies, Inc. is engaged in enabling implantable and interventional medical devices to operate safely and compatibly with MRI (Magnetic Resonance Imaging) diagnostic equipment. The Company has developed several technologies that improve the safety of medical devices in the presence of an MRI machine. Research Report …
	Biolase Technology BLTI - NasdaqNM BLTI is a medical technology company that designs, develops, manufactures and markets advanced dental, cosmetic and surgical products. Research Report…
	Discovery Labs DSCO - NasdaqSC DSCO a development stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. Research Report…
	World Heart Corporation WHBT - NasdaqNM World Heart Corporation operates a global scale medical device business focused initially on HeartSaver. Initially developed by, CVD, HeartSaver is designed to be an affordable, fully implantable heart assist device to provide long-term support of pulsatile blood flow to patients suffering from heart failure and to permit the recipient to return to near normal activities. Financing News...
	Spectrx Inc SPRX - OTC BB SpectRx, Inc. is a medical technology company focused on insulin delivery and glucose monitoring products for the diabetes management market and biophotonic devices and technology for the non-invasive cancer diagnostics market. Historically, the Company's technology has been primarily based upon biophotonic technology, which it defines as the use of light and other forms of energy to access the human body to diagnose and monitor disease. Financing Report...
	Generex Biotechnology Corp. GNBT - NasdaqSC Generex Biotechnology Corporation is a development stage company engaged primarily in the research and development of drug delivery technologies. Its focus is the development of its technology for the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator. Research Report..

Financing Structure >>>